Titlebook: Onconephrology; Cancer, Chemotherapy Kenar D. Jhaveri,Abdulla K. Salahudeen Book 2015 Springer Science+Business Media LLC 2015 Nephrectomy.

十字架

Junction

Kenar D. Jhaveri,Abdulla K. SalahudeenCovers the pathophysiology and management of kidney diseases in cancer patients.Case based resource features the latest evidence and clinical approaches.Fills a significant knowledge gap for nephrolog

Esophagus

Compatriot

機構(gòu)

expdient

Electrolyte Disorders in Cancer Patients,chapter describes the frequency of the most commonly observed electrolyte disorders in the oncology patient and delves into the unique cancer- or chemotherapy-related etiology of these clinical problems.

的染料

Renal Cell Carcinoma and Chronic Kidney Disease,es that affect long-term mortality and morbidity. In this population, chronic kidney disease (CKD), due to both underlying conditions as well as loss of renal mass, has become a key determinant of long-term outcomes.

Assault

平息

Biological Cancer Therapies and the Kidney,KD) due to chemotherapy. Nephrologists need to be aware of the presentation, prevention, and treatment of toxicities associated with targeted therapies. This chapter will review the kidney toxicities of antiangiogenic therapies, of epidermal growth factor receptor (EGFR) inhibitors, and of other multi-targeted tyrosine kinase inhibitors (TKI).

宇宙你